Literature DB >> 7101727

Characterization of monoclonal antibodies against the G1 and N proteins of LaCrosse and Tahyna, two California serogroup bunyaviruses.

F Gonzalez-Scarano, R E Shope, C E Calisher, N Nathanson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7101727     DOI： 10.1016/0042-6822(82)90005-8

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  26 in total

1.  Comparative analysis of G1 glycoprotein-coding sequences of Cache Valley virus (Bunyaviridae: Bunyavirus) isolates.

Authors:  C L Brockus; P R Grimstad
Journal:  Virus Genes       Date:  2001-03       Impact factor: 2.332

2.  Characterization of La Crosse virus RNA in autopsied central nervous system tissues.

Authors:  L J Chandler; M K Borucki; D K Dobie; L P Wasieloski; W H Thompson; C B Gundersen; K Case; B J Beaty
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

3.  La Crosse virus nonstructural protein NSs counteracts the effects of short interfering RNA.

Authors:  Samantha S Soldan; Matthew L Plassmeyer; Meghan K Matukonis; Francisco González-Scarano
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes.

Authors:  Georg Kochs; Christian Janzen; Heinz Hohenberg; Otto Haller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

5.  Virulence of La Crosse virus is under polygenic control.

Authors:  R S Janssen; N Nathanson; M J Endres; F Gonzalez-Scarano
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

6.  Bunyavirus Taxonomy: Limitations and Misconceptions Associated with the Current ICTV Criteria Used for Species Demarcation.

Authors:  Bradley J Blitvich; Barry J Beaty; Carol D Blair; Aaron C Brault; Gerhard Dobler; Michael A Drebot; Andrew D Haddow; Laura D Kramer; Angelle Desiree LaBeaud; Thomas P Monath; Eric C Mossel; Kenneth Plante; Ann M Powers; Robert B Tesh; Michael J Turell; Nikos Vasilakis; Scott C Weaver
Journal:  Am J Trop Med Hyg       Date:  2018-04-19       Impact factor: 2.345

7.  Mutagenesis of the La Crosse Virus glycoprotein supports a role for Gc (1066-1087) as the fusion peptide.

Authors:  Matthew L Plassmeyer; Samantha S Soldan; Karen M Stachelek; Susan M Roth; Julio Martín-García; Francisco González-Scarano
Journal:  Virology       Date:  2006-10-05       Impact factor: 3.616

8.  Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies.

Authors:  A Pekosz; C Griot; K Stillmock; N Nathanson; F Gonzalez-Scarano
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

9.  Polygenic control of neuroinvasiveness in California serogroup bunyaviruses.

Authors:  C Griot; A Pekosz; D Lukac; S S Scherer; K Stillmock; D Schmeidler; M J Endres; F Gonzalez-Scarano; N Nathanson
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates.

Authors:  A V Albright; J T Shieh; T Itoh; B Lee; D Pleasure; M J O'Connor; R W Doms; F González-Scarano
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.